VYNDAMAX® (tafamidis) PBS-listed for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association (NYHA) Class I-II heart failure May 4, 2024 — 18:00
INMOTION Debuts Innovational 2-in-1 Self-balancing Vehicle E20 at Global Sources HK Show 2024 April 25, 2024 — 23:50
Terra Drone, Unifly, and Aloft Technologies Launch UTM Development for AAM Targeting Global Markets April 25, 2024 — 07:00